Cancer Trend Report Highlights Specialty Pharmacy Week in Review
Top stories of the week on Specialty Pharmacy Times from May 25 to May 29.
Top stories of the week on Specialty Pharmacy Times from May 25 to May 29.
New Cancer Cases Rise as Cancer Deaths Fall
Treatment advances have caused significant progress in survivorship.
Redesigned Antibody May Control HIV Infection
Discovery may accelerate search for effective vaccine.
Can Providers Predict Which Patients Will Respond to Multiple Sclerosis?
Genetic variant found to be associated with the likelihood of patient response to interferon-beta.
New Insulin Pen Strength Gets FDA Nod
Treatment is the first concentrated mealtime insulin analog to be approved by the FDA.
New Treatment Target Found for Rheumatoid Arthritis
Novel drug target found in cells directly responsible for cartilage damage in affected joints.
Psoriasis Drug Development Pact Dissolved Due to Suicide Concerns
Treatment blocks signals that may lead to inflammation.
Molecular Treatment Strategy May Kill Lung Cancer Cells
Protein that helps cancer cells avoid death offers promising target.
Immune Cell Injections Safe and Effective for Multiple Myeloma
Treatment utilizes immune cells grown from patient bone marrow to treat multiple myeloma.
FDA Approves Treatment for Rare Lung Disease
Patients who took the drug had a slower decline in lung function than those on placebo.
Vaccine Vial Monitor Systems Critical in Polio Eradication Effort
Monitors alert health workers when a vaccine has potentially been compromised by cold chain failures.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Effectively Managing Immunizations in the Long-Term Care SettingSeptember 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet DevelopmentSeptember 18th 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
